The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
Yu FuXiaowan ChenYongxi SongXuanzhang HuangQuan ChenXinger LvPeng GaoZhen-Ning WangPublished in: BMC cancer (2021)
PLR is an effective marker to predict the effects of chemotherapy in patients with stage II CRC.